Levant is an established company operating in Zambia and focusing on top notch medical and pharmaceutical products.
Levant cares about quality health and puts the Zambian patients at the center of its attention.
Levant is the best employer at its field.
Due to our expansion we are looking for an ambitious ,self motivated ,result oriented and committed medical representatives.
Candidates will be reporting to a line sales manager and will be responsible of the following duties:
- Establish new accounts by organizing and planning daily work schedule to build on existing or potential sales outlets.
- Enlisting products at the selected accounts through promotion.
- Deliver agreed message to the targeted segment.
- Study potentiality per account and forecasting sales targets accordingly.
- Make and submit sales orders.
- Gather current marketplace information on newly introduced products.
- Investigate problems; prepare reports; develop solutions, and make recommendations to management in order to meet customers’ expectations.
- Prepare and conduct educational activities to the selected specialty.
- Provide historical records by keeping records on customer inquiries and sales.
- Contribute to team efforts in accomplishing organizational goals.
Requirements – PREVIOUS WORK EXPERIENCE IN A PHARMACEUTICAL IS A MUST.
- Previous work experience in a pharmaceutical field is a must
- Valid driving license is a must
- Customer service oriented, with the ability to meet sales goals
- Possess self-confidence, positive mentality, with the ability to manage territories effectively
- Reliable, hardworking, enthusiastic, with the ability to perform multiple assignments at the same time.
A competitive package is offered including basic salary, annual incentives ,training, opportunities for growth and carrier development as well as a car allocation, according to performance.
ATTACH ONLY DETAILED CV AND INDICATE EITHER LAB DIVISION OR PHARMA AS SUBJECT.
To apply for this job email your details to hr@Levantbiotech.com
Closing Date : 4th March, 2024.
